BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11753673)

  • 1. Cell transformation by the middle T-antigen of polyoma virus.
    Ichaso N; Dilworth SM
    Oncogene; 2001 Nov; 20(54):7908-16. PubMed ID: 11753673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between src-kinases and the polyoma virus oncogene middle T-antigen requires PP2A and a specific sequence motif.
    Glover HR; Brewster CE; Dilworth SM
    Oncogene; 1999 Jul; 18(30):4364-70. PubMed ID: 10439044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell fractionation in non-ionic detergent distinguishes sub-populations of polyoma virus middle T antigen and reveals a novel form.
    Krauzewicz N; Elliott J; Griffin BE
    Oncogene; 1994 Aug; 9(8):2283-91. PubMed ID: 7518577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyoma virus middle tumor antigen stimulates membrane-associated protein kinase C at lower levels than required for phosphatidylinositol kinase activation and neoplastic transformation.
    Marcellus R; Whitfield JF; Raptis L
    Oncogene; 1991 Jun; 6(6):1037-40. PubMed ID: 1648699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of cytokeratin 14 gene expression by the polyoma virus middle T antigen is dependent on c-Src association but independent of full transformation in rat liver nonparenchymal epithelial cells.
    Royal I; Raptis L; Druker BJ; Marceau N
    Cell Growth Differ; 1996 Jun; 7(6):737-43. PubMed ID: 8780887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming gene of polyoma virus.
    Dilworth SM; Griffin BE
    Arch Geschwulstforsch; 1983; 53(3):187-95. PubMed ID: 6311133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of AP-1 constitutive activity interferes with polyomavirus MT antigen transformation ability.
    Winnischofer SM; de Oliveira ML; Sogayar MC
    J Cell Biochem; 2003 Oct; 90(2):253-66. PubMed ID: 14505342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domains in middle-T antigen that cooperate in polyomavirus-mediated oncogenic transformation.
    Pérez L; Urich M; Paasinen A; Senften M; Meili R; Ballmer-Hofer K
    Virology; 1995 Apr; 208(1):26-37. PubMed ID: 11831708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
    DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
    Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevation of cellular phosphatidic acid levels caused by polyomavirus transformation can be disassociated from the activation of phospholipase D.
    Vasudevan C; Freund R; Gorga FR
    Virology; 1997 Jul; 233(2):392-401. PubMed ID: 9217062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.
    Rouleau C; Pores Fernando AT; Hwang JH; Faure N; Jiang T; White EA; Roberts TM; Schaffhausen BS
    J Virol; 2016 Aug; 90(16):7032-7045. PubMed ID: 27194756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue specificity of oncogene action: endothelial cell tumours in polyoma middle T transgenic mice.
    Bautch VL; Toda S; Hassell JA; Hanahan D
    IARC Sci Publ; 1989; (96):255-66. PubMed ID: 2807487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoma virus middle T antigen and its role in identifying cancer-related molecules.
    Dilworth SM
    Nat Rev Cancer; 2002 Dec; 2(12):951-6. PubMed ID: 12459733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A large T-antigen of SV40 virus: involvement in replication of cellular DNA and interactions with nuclear proteins].
    Vasetskiĭ ES; Meshali M
    Ontogenez; 1998; 29(3):170-7. PubMed ID: 9702793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
    Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
    Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.
    Utermark T; Schaffhausen BS; Roberts TM; Zhao JJ
    J Virol; 2007 Jul; 81(13):7069-76. PubMed ID: 17442716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
    Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
    Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses.
    White MK; Khalili K
    Oncogene; 2006 Aug; 25(38):5286-93. PubMed ID: 16936749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C stimulation increases the transforming ability of the polyoma virus middle T antigen.
    Raptis L; Whitfield JF
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1106-12. PubMed ID: 2430571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.